Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Zydus Lifesciences gains FDA approval for Cyclophosphamide Capsules Zydus Lifesciences Limited, a leading pharmaceutical company, has achieved a significant milestone by receiving final approval from the… byPallavi MadhirajuDecember 17, 2023